Long-Chain Fatty Acids Inhibit Myeloid-Derived Suppressor Cells to Delay Tumor Progression

Area of Science:

• Immunology
• Metabolic pathways
• Cancer biology

Background:

• Tumor progression is influenced by host metabolism.
• Mechanisms of metabolic modulation in the tumor immune microenvironment are not fully understood.
• Myeloid-derived suppressor cells (MDSCs) are key regulators of the tumor immune microenvironment.

Purpose of the Study:

• To investigate the role of long-chain fatty acids (LCFAs) in modulating myeloid-derived suppressor cells (MDSCs).
• To explore the impact of LCFAs on the tumor immune microenvironment and cancer progression.

Main Methods:

• In vitro and in vivo experiments exposing MDSCs to LCFAs.
• Analysis of immunosuppressive gene expression in monocytic MDSCs (M-MDSCs) and polymorphonuclear MDSCs (PMN-MDSCs).
• Assessment of tumor progression and survival in mice fed high-LCFA diets, including experiments with nude mice.

Main Results:

• LCFA exposure significantly reduced immunosuppressive gene expression in both M-MDSCs and PMN-MDSCs.
• Mice on high-LCFA diets showed delayed tumor progression and prolonged survival across various cancer models.
• LCFA-induced inhibition of MDSCs correlated with enhanced CD8+ T cell antitumor immunity, an effect absent in nude mice.

Conclusions:

• Long-chain fatty acids (LCFAs) directly modulate MDSC function, reducing their immunosuppressive capacity.
• Dietary LCFAs can inhibit tumor progression and enhance antitumor immunity by targeting MDSCs.
• LCFAs represent a novel therapeutic avenue for cancer treatment by influencing the tumor immune microenvironment.